Beijing Tong Ren Tang Chinese Medicine Company Limited Stock
Equities
3613
HK0000145638
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.83 HKD | +0.82% | -5.24% | -19.60% |
Sales 2024 * | 1.74B 222M | Sales 2025 * | 1.99B 255M | Capitalization | 8.16B 1.05B |
---|---|---|---|---|---|
Net income 2024 * | 652M 83.49M | Net income 2025 * | 758M 97.07M | EV / Sales 2024 * | 3.07 x |
Net cash position 2024 * | 2.83B 363M | Net cash position 2025 * | 2.63B 337M | EV / Sales 2025 * | 2.78 x |
P/E ratio 2024 * |
12.6
x | P/E ratio 2025 * |
9.72
x | Employees | 798 |
Yield 2024 * |
4.1% | Yield 2025 * |
4.77% | Free-Float | 28.23% |
1 day | +0.10% | ||
1 week | -5.24% | ||
Current month | +1.99% | ||
1 month | +5.40% | ||
3 months | +3.06% | ||
6 months | -24.46% | ||
Current year | -19.60% |
Managers | Title | Age | Since |
---|---|---|---|
Fung Yi Tsang
DFI | Director of Finance/CFO | 48 | 12-09-30 |
Xia Li
CTO | Chief Tech/Sci/R&D Officer | 54 | 07-12-31 |
Fei Chen
BRD | Director/Board Member | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ngai Chi Chan
BRD | Director/Board Member | 52 | 13-04-14 |
Hai Ou Gu
CHM | Chairman | 58 | Dec. 12 |
Yok Sing Tsang
BRD | Director/Board Member | 76 | 17-09-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +3.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 9.83 | +0.82% | 139 000 |
24-05-23 | 9.75 | -4.97% | 4,578,000 |
24-05-22 | 10.26 | +3.74% | 3,663,000 |
24-05-21 | 9.89 | -3.04% | 2,174,000 |
24-05-20 | 10.2 | -0.97% | 1,380,000 |
Delayed Quote Hong Kong S.E., May 23, 2024 at 09:41 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.60% | 1.1B | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- 3613 Stock